Patent details

Basic Information

Publication number:

EP3791883

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP201915998

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

METHOTREXATE FOR PROLIFERATIVE VITREORETINOPATHY

French Title of Invention:

MÉTHOTREXATE POUR LE TRAITEMENT DE LA VITRÉORÉTINOPATHIE PROLIFÉRANTE

German Title of Invention:

METHOTREXAT ZUR PROLIFERATIVEN VITREORETINOPATHIE

SPC Number:

Dates

Filing date:

30/07/2015

Grant date:

25/10/2023

EP Publication Date:

17/03/2021

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

25/10/2023

EP B1 Publication Date:

25/10/2023

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

30/07/2024

Expiration date:

30/07/2035

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

18/10/2023

 

 

Name:

Massachusetts Eye & Ear Infirmary

Address:

243 Charles Street, Boston, MA 02114, United States (US)

Inventor

1

Name:

ELIOTT, Dean

Address:

United States (US)

2

Name:

STRYJEWSKI, Tomasz P.

Address:

United States (US)

Priority

Priority Number:

201462030778 P

Priority Date:

30/07/2014

Priority Country:

United States (US)

Classification

IPC classification:

A61K 31/519; A61K 9/00; A61P 27/02;

Publication

European Patent Bulletin

1

Issue number:

202343

Publication date:

25/10/2023

Description:

Grant (B1)

2

Issue number:

202348

Publication date:

29/11/2023

Description:

Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages